Diamonds and Dogs

July 9th, 2010

Google, GOOG
Google shares were up early in the trading day as a licensing agreement with China was finally made. The problem stemmed from Google no longer willing to obey China's self censorship rules due to the government putting new limits on free speech and Google suspecting multiple cyber-attacks to have begun in China. China has the most internet users in the world so it comes as no surprise that the contract was worthwhile for Google. Shares were up 2.54% or $11.6 to 468.16.

GlaxoSmithKline PLC Common Stock, GSK
Not too many dogs in the early market but one that has emerged is GlaxoSmithKline. This pharmaceutical company has its leading diabetes drug, Avandia, being reviewed by European regulators. The drug is suspected to be causing or exacerbating cardiovascular problems in many its users. The shares for the stock fell almost 1%, .34, to $34.57.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.